- Drug discovery startup Unnatural Products, Inc. pairing AI with chemistry to create treatments for drug targets raise $6M in funding led by ARTIS Ventures. - Unnatural Products uses a combination of machine learning and parallel chemistry to change the way we think about treating disease Today ARTIS Ventures has led a $6 million seed round for Unnatural Products, Inc., a Santa Cruz, CA-based drug discovery startup pairing AI with chemistry to create treatments for drug targets that aren’t
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Ensuring A Healthy Approach to Big Data In The Life Sciences Industry
The old adage “knowledge is power” may seem cliched, but it definitely still rings true in the life sciences industry. In fact, maybe more so than in any other industry, healthcare insights are being driven by a vast array of critically important data from scientific research, clinical trials, and patient profiling. Teams are continually asked to identify, prioritize and develop promising therapies which are not only safe but innovative, effective and based on the latest research.
To achieve
Read More
BrightInsight Nabs $25M for Regulated IoT Platform for Biopharma and Medtech
- BrightInsight raises $25M in Series A funding co-led by New Leaf Venture Partners and Eclipse Ventures to further enhance the functionality of its BrightInsight Platform and accelerate global commercialization efforts.
- BrightInsight platform enables regulated drugs, devices and SaMDs to ingest and analyze data and deploy regulated recommendations and insights back to patients and providers
BrightInsight, San Jose, CA-based global regulated digital health platform for biopharma and
Read More
Life Image Launches Real World Imaging for RWE Programs
- Life Image launches Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisions.
- Imaging data, especially for Real World Evidence (RWE), has historically been difficult, if not impossible, to access, retrieve, view, de-identify and normalize at-scale, even though it provides clinically material insights for a growing number of therapies.
- Life Image represents the only company providing large, heterogeneous,
Read More
Tufs Study: Cancer Drugs Now Account for 27% of all New Drug Approvals
Quick Glance- Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010- From 1980 through 2018, the Food and Drug Administration (FDA) approved a total of 126 cancer drugs to treat solid and hematologic tumors- New approaches to development helped to drive the surge in new oncology products, including improvements in clinical trial design, novel drug formats, and a focus on new and validated targetsCancer drugs currently account for 27% of all new drug
Read More
KPMG, Coriell Life Sciences Collaborate on Pharmacogenomics Testing
Coriell Life Sciences will provide pharmacogenomic tests for clients of KPMG’s Care Continuum Optimization, a cloud-based data platform aimed at improving healthcare outcomes and guiding clinicians through transitions in care. Coriell will be running the tests on Thermo Fisher Scientific technology to provide alerts to prescribers when there is the potential for an adverse drug event tied to a patient’s genetics and recommend safer treatment options.KPMG’s Care Continuum Optimization
Read More
Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative
In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
Litmus Health Launches Next-Generation Data Science Platform for Clinical Research
Litmus Health, the research-ready infrastructure platform for real-world data has announced the release of the next generation of their platform focused on reliable data engineering, data quality, and flexible deployment. The end-to-end platform supports the entire trial process: from data collection at the point of experience to laboratory analytics that can inform decision making.Pharma Industry Increasingly Turning to Real-World DataThe pharmaceutical industry has been increasingly looking
Read More
Benchling Nabs $34.5M to Power Life Sciences R&D Cloud Platform
Benchling, a San
Francisco, CA-based life sciences R&D cloud platform announced it has raised
$34.5 million in Series C funding led by Menlo Ventures with new investors Lead
Edge Capital and Y Combinator Continuity as well as returning investors
Benchmark and Thrive Capital.
Replacing Outdated Pen and Paper Processes
Life science R&D has become incredibly complex -- from
the molecules to the processes to the multi-dimensional data. Until Benchling, there had been
Read More
Atomwise, Enamine Launches AI-Powered 10 Billion Compound Virtual Drug Screen for Pediatric Oncology
Atomwise announced the launch of a 10 billion compound AI-powered virtual drug screening initiative for pediatric oncology, in collaboration with Enamine Ltd., the world’s largest chemical supplier. The goal of this initiative – called the 10-to-the-10 program – is to dramatically increase the discovery of safer small molecules to treat pediatric cancers. When completed, it will stand as the largest ever virtual drug screen. 10-to-the-10 Program OverviewCancer is diagnosed in more than 15,000
Read More
